Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study-Reference-Cited by-同舟云学术

Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study

Published:2023-11-23 Issue:1 Volume:56 Page:66-72
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Morais Samantha¹,Wissing Michel D.¹,Khosrow-Khavar Farzin¹,Burchell Ann N.²,Tellier Pierre-Paul³,Coutlée François¹⁴,Waterboer Tim⁵,El-Zein Mariam¹,Franco Eduardo L.¹

Affiliation:

1. Division of Cancer Epidemiology, McGill University, Montreal, Canada

2. Department of Family and Community Medicine and MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada

3. Department of Family Medicine, McGill University, Montreal, Canada

4. Laboratoire de Virologie Moléculaire, Centre de Recherche du Centre Hospitalier de l‘Université de Montréal (CRCHUM), et Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Canada

5. Infections and Cancer Epidemiology Division, German Cancer Research Center, Heidelberg, Germany

Funder

Canadian Institutes of Health Research

United States National Institutes of Health

Merck Frosst Canada Ltd, and Merck & Co Ltd

CIHR Postdoctoral Fellowship Award

CIHR HIV/AIDS and STBBI Research Initiative

CIHR Institute of Infection and Immunity, Postdoctoral Fellowship Award

University of Toronto Department of Family and Community Medicine non-clinician scientist award

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2023.2277390

Reference15 articles.

1. The spectrum and clinical sequelae of human papillomavirus infection

2. Classification of papillomaviruses

3. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC; 2007.

4. Government of Canada. Human papillomavirus vaccine: Canadian Immunization Guide. 2021 https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-9-human-papillomavirus-vaccine.html.

5. Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines